burke development associates limited liability company

1390 broadway, apt 21c
new york, new york 10023

NYS Entity Status
ACTIVE

NYS Filing Date
MAY 07, 2013

NYS DOS ID#
4399693

County
NEW YORK

Jurisdiction
NEW JERSEY

Registered Agent
NONE

NYS Entity Type
FOREIGN LIMITED LIABILITY COMPANY

Name History
2013 - BURKE DEVELOPMENT ASSOCIATES LIMITED LIABILITY COMPANY









Buffer

submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • Woody Allen’s ‘Wonder Wheel’ set to close NY Film Festival
    By Deadline - Tuesday Jul 25, 2017

    The film will go into limited release December 1.

    Source: New York Post: Entertainment
  • Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
    By Ben Fidler - Tuesday Sep 12, 2017

    Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]

    Source: Xconomy New York
  • New Development: Soft in the Middle, Splashy Up Top
    By STEFANOS CHEN - Friday Sep 15, 2017

    The luxury market in New York is pulling in two directions, with developers betting on big-ticket palatial aeries and million-dollar “starter” homes.

    Source: NYT > Home Page
  • Knicks add Trey Burke to chaotic point-guard situation
    By Marc Berman - Wednesday Oct 11, 2017

    With Joakim Noah’s drug suspension for the first 12 games, the Knicks are granted an extra roster spot and likely will use it on a point guard. On Wednesday, the Knicks may have found one. They signed former Utah point guard Trey Burke to a non-guaranteed contract. He’s likely not here to solve their point-guard...

    Source: New York Post: Sports
  • Express Scripts to limit opioids; doctors concerned
    By Jim Salter - Wednesday Aug 16, 2017

    ST. LOUIS — The largest U.S. pharmacy benefit manager will soon limit opioid drugs for first-time users as part f a wide-ranging effort to curb an epidemic.[...] the new program from Express Scripts is drawing criticism from the American Medical Association, the largest association of physicians and medical students in the U.S., which believes treatment plans should be left to doctors and patients.Express Scripts started a yearlong pilot program in 2016 to reduce patients’ dependency on opioids and the risk of addiction, said Snezana Mahon, the company’s vice president of clinical product development.Mahon said analysis of 106,000 patients in the program showed a 38 percent reduction in hospitalizations and a 40 percent drop in emergency room visits, compared with a control group.The program is scheduled to take effect nationwide on Sept. 1 for Express Scripts members whose employer or health insurer has enrolled to participate.Dosage is also limited, and the company will monitor and try to prevent for patterns of potential “pill shopping,” where a patient goes from doctor to doctor to collect prescriptions.Harris said doctors have reduced such prescriptions by 17 percent over the past couple of years and are directing patients to other forms of pain management, including physical therapy and cognitive behavioral therapy.

    Source: SFGATE.com: Business and Technology News